Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017175060) MEDICINAL PLANTS
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2017/175060 International Application No.: PCT/IB2017/000439
Publication Date: 12.10.2017 International Filing Date: 28.03.2017
IPC:
C12N 15/29 (2006.01) ,A01H 5/00 (2006.01) ,A61K 47/64 (2017.01) ,C07K 14/415 (2006.01) ,C07K 19/00 (2006.01) ,C12N 15/56 (2006.01) ,C12N 15/82 (2006.01) ,C12N 9/24 (2006.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09
Recombinant DNA-technology
11
DNA or RNA fragments; Modified forms thereof
29
Genes encoding plant proteins, e.g. thaumatin
A HUMAN NECESSITIES
01
AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
H
NEW PLANTS OR PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
5
Flowering plants, i.e. angiosperms
[IPC code unknown for A61K 47/64]
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
415
from plants
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
19
Hybrid peptides
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09
Recombinant DNA-technology
11
DNA or RNA fragments; Modified forms thereof
52
Genes encoding for enzymes or proenzymes
55
Hydrolases (3)
56
acting on glycosyl compounds (3.2), e.g. amylase, galactosidase, lysozyme
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09
Recombinant DNA-technology
63
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
79
Vectors or expression systems specially adapted for eukaryotic hosts
82
for plant cells
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
9
Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
14
Hydrolases (3.)
24
acting on glycosyl compounds (3.2)
Applicants:
OPHIUCHUS MEDICINE INC. [CA/CA]; CA
Inventors:
HASSAN, Yasser, Salim; CA
Priority Data:
62/317,67904.04.2016US
Title (EN) MEDICINAL PLANTS
(FR) PLANTES MÉDICINALES
Abstract:
(EN) In one aspect the invention comprises a transgenic garlic plant expressing pokeweed antiviral protein or a fusion protein comprising pokeweed antiviral protein and ricin A-chain. Garlic plants comprising this transgene may possess greater resistance to disease and may provide benefits to animals that consume the plant as antivirals. In another aspect, the invention comprises a vector comprising a polynucleotide that encodes pokeweed antiviral protein or a fusion protein comprising pokeweed antiviral protein and ricin A-chain. In yet another aspect, the invention comprises a fusion protein comprising pokeweed antiviral protein or a fusion protein comprising pokeweed antiviral protein and ricin A-chain. The fusion protein may be delivered to a subject as an extract or in combination with a pharmaceutical excipient as an antiviral agent.
(FR) Dans un aspect l'invention comprend un plant d'ail transgénique exprimant la protéine antivirale de la phytolaque ou une protéine de fusion comprenant la protéine antivirale de la phytolaque et la chaîne A de la ricine. Les plants d'ail comprenant ce transgène peuvent posséder une résistance supérieure aux maladies et peuvent fournir des bénéfices aux animaux qui consomment la plante comme antiviral. Dans un autre aspect, l'invention comprend un vecteur comprenant un polynucléotide qui code pour une protéine antivirale de phytolaque ou une protéine de fusion comprenant la protéine antivirale de phytolaque et la chaîne A de la ricine. Dans encore un autre aspect, l'invention comprend une protéine de fusion comprenant la protéine antivirale de phytolaque ou une protéine de fusion comprenant la protéine antivirale de phytolaque et la chaîne A de la ricine. La protéine de fusion peut être administrée à un sujet sous la forme d'un extrait ou en combinaison avec un excipient pharmaceutique comme agent antiviral.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)